Imexpharm (STC:IMP) Long-Term Debt: ₫100,000 Mil (As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫42,700.00
GF Value ₫52,094.23
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Long-Term Debt?

Imexpharm STC:IMP +3.64% 98 Long-Term Debt is ₫100,000 Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 98/100 and a GF Value™ of ₫52,094.23 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Imexpharm's Long-Term Debt for the quarter that ended in Mar. 2026 was ₫100,000 Mil.

Imexpharm's quarterly Long-Term Debt declined from Sep. 2025 (₫170,000 Mil) to Dec. 2025 (₫100,000 Mil) but then stayed the same from Dec. 2025 (₫100,000 Mil) to Mar. 2026 (₫100,000 Mil).

Imexpharm's annual Long-Term Debt stayed the same from Dec. 2023 (₫0 Mil) to Dec. 2024 (₫0 Mil) but then increased from Dec. 2024 (₫0 Mil) to Dec. 2025 (₫100,000 Mil).

Imexpharm  (STC:IMP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Imexpharm Long-Term Debt Related Terms

Imexpharm Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Imexpharm's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Long-Term Debt Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 100,000.00

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 250,000.00 250,000.00 170,000.00 100,000.00 100,000.00
STC:IMP
98GF Score
Imexpharm Corp STC:IMP
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₫100,000 Mil mean?
Imexpharm (STC:IMP) has a Long-Term Debt of ₫100,000 Mil as of Mar. 2026.
Is Imexpharm's Long-Term Debt too high?
Imexpharm's current Long-Term Debt is ₫100,000 Mil. Overall, Imexpharm has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Long-Term Debt compare to ZTS and UTHR?
Imexpharm's Long-Term Debt of ₫100,000 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Imexpharm's current Long-Term Debt is ₫100,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫52,094.23, compared to a current price of ₫42,700.00 — trading 18% below its estimated fair value. The current Long-Term Debt is ₫100,000 Mil. Imexpharm's overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Long-Term Debt is ₫100,000 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,700.00 is trading 18% below its estimated GF Value™ of ₫52,094.23. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Long-Term Debt: ₫100,000 Mil
  • GF Value™: ₫52,094.23 vs. price of ₫42,700.00 (18% below fair value)
  • GF Score™: 98/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,700.00
Price
₫52,094.23
GF Value